Association study of Notch 4 polymorphisms with Alzheimer's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 3, 2004, Pages 377-381

  Lambert, J C ^a,b   Mann, D ^d   Harris, J ^c   Araria Goumidi, L ^b   Chartier Harlin, M C ^b   Cottel, D ^b   Iwatsubo, T ^e   Amouyel, P ^b   Lendon, C ^c  

^a INSERM   (France)

^b INSTITUT PASTEUR DE LILLE   (France)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d Greater Manchester Neurosciences Centre   (United Kingdom)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; DNA BINDING PROTEIN; NOTCH RECEPTOR; NOTCH4 RECEPTOR; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTOMA CELL; CONTROLLED STUDY; FEMALE; FRANCE; GEL MOBILITY SHIFT ASSAY; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENOTYPE; GLIOMA CELL; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROBLASTOMA CELL; OUTCOMES RESEARCH; POPULATION RESEARCH; PRIORITY JOURNAL; PROMOTER REGION; UNITED KINGDOM;

5' UNTRANSLATED REGIONS; AGE OF ONSET; AGED; ALZHEIMER DISEASE; CHROMOSOMES, HUMAN, PAIR 6; CROSS-SECTIONAL STUDIES; ENGLAND; FEMALE; FRANCE; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; GENOTYPE; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROTO-ONCOGENE PROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, NOTCH; RISK FACTORS; SCOTLAND;

EID: 1542721838     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2003.017368     Document Type: Article

References (22)

1. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA 1997;278:1349-56.
2. Myers A, Wavrant De-Vrieze F, Holmans P, et al. Full genome screen for Alzheimer disease: stage II analysis. Am J Med Genet 2002;114:235-44.
3. Blacker D, Bertram L, Saunders AJ, et al. Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet 2003;12:23-32.
4. Zareparsi S, James DM, Kaye JA, et al. HLA-A2 homozygosity but not heterozygosity is associated with Alzheimer disease. Neurology 2002;58:973-5.
5. Harris JM, Cumming AM, Craddock N, et al. Human leucocyte antigen-A2 increases risk of Alzheimer's disease but does not affect age of onset in a Scottish population. Neurosci Lett 2000;294:37-40.
6. Collins JS, Perry RT, Watson B, et al. Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer Disease Genetics Initiative. Am J Med Genet 2000;96:823-30.
7. Araria-Goumidi L, Lambert JC, Cottel D, et al. No association of the HLA-A2 allele with Alzheimer's disease. Neurosci Lett 2002;335:75-8.
8. Infante J, Llorca J, Berciano J, et al. No synergistic effect between -850 tumor necrosis factor-alpha promoter polymorphism and apolipoprotein E epsilon 4 allele in Alzheimer's disease. Neurosci Lett 2002;328:71-3.
9. Hitoshi S, Alexson T, Tropepe V, et al. Notch pathway molecules are essential for the maintenance, but not the generation, of mammalian neural stem cells. Genes Dev 2002;16:846-58.
10. Irvin DK, Zurcher SD, Nguyen T, et al. Expression patterns of Notch1, Notch2, and Notch3 suggest multiple functional roles for the Notch-DSL signaling system during brain development. J Comp Neurol 2001;436:167-81.
11. Joutel A, Corpechot C, Ducros A, et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996;383:707-10.
12. Wei J, Hemmings GP. The NOTCH4 locus is associated with susceptibility to schizophrenia. Nat Genet 2000;25:376-7.
13. Fan JB, Tang JX, Gu NF, et al. A family-based and case-control association study of the NOTCH4 gene and schizophrenia. Mol Psychiatry 2002;7:100-3.
14. Iwatsubo T, Odaka A, Suzuki N, et al. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 1994;13:45-53.
15. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990;31:545-8.
16. Ujike H, Takehisa Y, Takaki M, et al. NOTCH4 gene polymorphism and susceptibility to schizophrenia and schizoaffective disorder. Neurosci Lett 2001;301:41-4.
17. MacLean CJ, Morton NE. Estimation of myriad haplotype frequencies. Genet Epidemiol 1985;2:263-72.
18. Dignam JD, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 1983;11:1475-89.
19. Payami H, Schellenberg GD, Zareparsi S, et al. Evidence for association of HLA-A2 allele with onset age of Alzheimer's disease. Neurology 1997;49:512-18.
20. McCusker SM, Curran MD, Dynan KB, et al. Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study. Lancet 2001;357:436-9.
21. Lambert JC, Araria-Goumidi L, Myllykangas L, et al. Contribution of APOE promoter polymorphisms to Alzheimer's disease risk. Neurology 2002;59:59-66.
22. Lazarus R, Klimecki WT, Palmer LJ, et al. Single-nucleotide polymorphisms in the interleukin-10 gene: differences in frequencies, linkage disequilibrium patterns, and haplotypes in three United States ethnic groups. Genomics 2002;80:223-8.